First Trust Advisors’s Vaxart VXRT Stock Holding History

First Trust Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-68,621	Closed	-$546K	–	2601
2021 Q3	$546K	Buy	+68,621	New	+$565K	﹤0.01%	2262

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

First Trust Advisors's VXRT Position: Q4 2021 in Review

First Trust Advisors sold out of Vaxart (VXRT) in Q4 2021, closing a stake of 68,621 shares — an estimated $546K sold.

First Trust Advisors first reported a position in VXRT in Q3 2021 and held it in 1 quarter. The position peaked at $546K in Q3 2021. 147 funds tracked by Wall St. Rank hold VXRT as of Q4 2021.

First Trust Advisors reported no remaining Vaxart position as of Q4 2021 after selling out during the quarter.
First Trust Advisors sold 68,621 Vaxart shares in Q4 2021, an estimated $546K.
First Trust Advisors first reported a position in Vaxart in Q3 2021 and held it in 1 quarter.
First Trust Advisors's Vaxart position peaked at $546K in Q3 2021.
147 funds tracked by Wall St. Rank held Vaxart as of Q4 2021.

Based on First Trust Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.